Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
17.35
+0.04 (0.23%)
At close: Mar 9, 2026, 4:00 PM EDT
17.31
-0.04 (-0.23%)
After-hours: Mar 9, 2026, 4:04 PM EDT
Avalo Therapeutics Market Cap
Avalo Therapeutics has a market cap or net worth of $321.20 million as of March 9, 2026. Its market cap has increased by 331.72% in one year.
Market Cap
321.20M
Enterprise Value
209.39M
1-Year Change
331.72%
Ranking
Category
Stock Price
$17.35
Market Cap Chart
Since November 13, 2015, Avalo Therapeutics's market cap has increased from $34.50M to $321.20M, an increase of 831.00%. That is a compound annual growth rate of 24.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 313.90M | -4.68% |
| Dec 31, 2025 | 329.30M | 326.55% |
| Dec 31, 2024 | 77.20M | 957.53% |
| Dec 29, 2023 | 7.30M | -84.60% |
| Dec 30, 2022 | 47.40M | -75.17% |
| Dec 31, 2021 | 190.90M | -3.49% |
| Dec 31, 2020 | 197.80M | -16.79% |
| Dec 31, 2019 | 237.70M | 80.35% |
| Dec 31, 2018 | 131.80M | 58.03% |
| Dec 29, 2017 | 83.40M | 917.07% |
| Dec 30, 2016 | 8.20M | -71.63% |
| Dec 31, 2015 | 28.90M | -16.23% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Opus Genetics | 337.23M |
| Adlai Nortye | 328.78M |
| X4 Pharmaceuticals | 328.76M |
| Relmada Therapeutics | 326.33M |
| Rezolute | 323.04M |
| Greenwich LifeSciences | 319.90M |
| Protara Therapeutics | 316.16M |
| Nautilus Biotechnology | 312.61M |